GPhC Registered Pharmacy
Discreet Packaging
Next Day Delivery

Emtricitabine/Tenofovir (Generic Truvada) PrEP Treatment - 30 Tablets

£59.99

In Stock

200mg/245mg Oral tablet — 30 tablet

Pay in 4 interest-free payments of £15.00 with

3 interest-free payments of £20.00 with

18+, T&Cs apply. Credit subject to status.

Fast delivery in 1-2 business days

Discreet packaging

All orders are sent in plain, unbranded packaging.

Secure checkout

Product Information

Both of these active substances are antiretroviral medicines which are used to treat HIV infection. Emtricitabine is a nucleoside reverse transcriptase inhibitor and tenofovir is a nucleotide reverse transcriptase inhibitor.

Shipping & Returns

Free delivery

Free standard delivery on orders over £40 and typically arrive in 1–2 business days.

Returns

For full details on our returns policy, visit our delivery & returns page.

Need help?

Our pharmacy team is here to help. Get in touch if you have any questions about your order or need advice on a product.

What Emtricitabine/Tenofovir disoproxil Mylan is and what it is used for

Emtricitabine/Tenofovir disoproxil Mylan contains two active substances, emtricitabine and tenofovir disoproxil. Both of these active substances are antiretroviral medicines which are used to treat HIV infection. Emtricitabine is a nucleoside reverse transcriptase inhibitor and tenofovir is a nucleotide reverse transcriptase inhibitor. However, both are generally known as NRTIs and they work by interfering with the normal working of an enzyme (reverse transcriptase) that is essential for the virus to reproduce itself.

Emtricitabine/Tenofovir disoproxil Mylan is used to treat Human Immunodeficiency Virus 1 (HIV-1) infection in adults.
It is also used to treat HIV in adolescents aged 12 to less than 18 years who weigh at least 35 kg, and who have already been treated with other HIV medicines that are no longer effective or have caused side effects.
- Emtricitabine/Tenofovir disoproxil Mylan should always be used combined with other medicines to treat HIV infection.
- Emtricitabine/Tenofovir disoproxil Mylan can be administered in place of emtricitabine and tenofovir disoproxil used separately at the same doses.

People who are HIV positive can still pass on HIV when taking this medicine, although the risk is lowered by effective antiretroviral therapy. Discuss with your doctor the precautions needed to avoid infecting other people.

This medicine is not a cure for HIV infection. While taking Emtricitabine/Tenofovir disoproxil Mylan you may still develop infections or other illnesses associated with HIV infection.

Emtricitabine/Tenofovir disoproxil Mylan is also used to reduce the risk of getting HIV-1 infection in adults, and adolescents aged 12 years to less than 18 years who weigh at least 35 kg, when used as a daily treatment, together with safer sex practices: See section 2 for a list of precautions to take against HIV infection.

Benefits

Active Ingredients: Emtricitabine & Tenofovir Helps prevent and treat HIV 92-99% effective when taken correctly

Patient Information Leaflet

View Patient Information Leaflet (PDF)

Side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Possible serious side effects:

Lactic acidosis (excess lactic acid in the blood) is a rare but potentially life-threatening side effect. Lactic acidosis occurs more often in women, particularly if they are overweight, and in people with liver disease. The following may be signs of lactic acidosis:
deep rapid breathing
- drowsiness
- feeling sick (nausea), being sick (vomiting)
- stomach pain

If you think you may have lactic acidosis, get medical help immediately.

Any signs of inflammation or infection. In some patients with advanced HIV infection (AIDS) and a history of opportunistic infections (infections that occur in people with a weak immune system), signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. It is thought that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Autoimmune disorders, when the immune system attacks healthy body tissue, may also occur after you start taking medicines to treat HIV infection. Autoimmune disorders may occur many months after the start of treatment. Look out for any symptoms of infection or other symptoms such as:
muscle weakness
- weakness beginning in the hands and feet and moving up towards the trunk of the body - palpitations, tremor or hyperactivity

If you notice these or any symptoms of inflammation or infection, get medical help immediately. Please read the patient information leaflet for a full list of other side effects that can occur.

Ingredients

The active substances are emtricitabine and tenofovir. Each Emtricitabine/Tenofovir disoproxil film-coated tablet contains 200mg of emtricitabine and 245mg of tenofovir disoproxil (equivalent to 300.6 mg of tenofovir disoproxil succinate).
The other ingredients are lactose monohydrate, microcrystalline cellulose (E460), starch pregelatinised maize, croscarmellose sodium, magnesium stearate (E470b), poly(vinyl alcohol)(E1203), titanium dioxide (E171), macrogol 3350 (E1521), talc (E553B), indigo carmine aluminium lake (E132).